A practical reference on adipose tissue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Fei hua qing han (simplified Chinese: 飞花轻寒; traditional Chinese: 飛花輕寒; pinyin: Fēi huā qīng hán) is an apocryphal poem falsely attributed to Li Bai, an influential 8th-century Chinese poet. The poem attracted attention in the Chinese Internet community when some people deciphered a hidden message in it that says "Go to hell Japan, Koizumi must die" (日本去死, 小泉定亡). It was later revealed that the poem was written around 2003 to 2004. "Fei hua qing han" roughly means "a cold and flying chain of flowers".
Aerated chocolate is chocolate that has undergone foaming. It has a lower density than other types of chocolate, and a smoother mouthfeel as it melts. Aerated chocolate was first brought to market in 1935 by the British chocolate maker Rowntree's under the brand Aero. Although Rowntree patented the manufacturing process, other chocolate makers quickly began making their own products, and today several manufacturers make aerated chocolates. Aerated chocolate can be divided into four types. The most common, seen in Aero, has large bubbles and is produced under a vacuum, or by beating gas into liquid chocolate under pressure. Aerated chocolate with tiny bubbles uses the same beating gas method but with nitrogen. Aerated chocolates containing long tubes of air are extruded rather than moulded. The final type is an aerated chocolate with low fat content, held together by a skeleton of solid particles. They are made by first dissolving sugar, then forming an emulsion with other ingredients. It finally undergoes evaporation and drying or freeze drying to reduce the water content.
It suggests that this level is mostly fixed by factors that are hereditary or determined early in life, implying that any change to well-being is only temporary and will eventually revert to the individual's baseline.
Sources: en.wikipedia.org
Strategic Air Command (1946–1992) SACAT – (a) Semi Attended Customer Activated Terminal (Supermarket checkout) SACEUR – (p) Supreme Allied Commander EURope SACF - Semi Automatic Capsule Filler source SACLANT – (p) Supreme Allied Commander atLANTic SACLOS – (a) Semi-Automatic Command to Line of Sight SAD (s) Safford Regional Airport (IATA code) (a) Seasonal Affective Disorder Situational Awareness Display SADD – (a) originally Students Against Drunk Driving, now Students Against Destructive Decisions (U.S.
== Story == Medea is centered on Medea's calculated desire for revenge against her unfaithful husband. Medea is of divine descent and has the gift of prophecy. She married Jason and used her magic powers and advice to help him find and retrieve the golden fleece. The play is set in Corinth some time after Jason's quest for the Golden Fleece, where he met Medea. The play begins with Medea in a blind rage towards Jason for arranging to marry Glauce, the daughter of king Creon. The nurse, overhearing Medea's grief, fears what she might do to herself or her children. Creon, in anticipation of Medea's wrath, arrives and reveals his plans to send her into exile. Crouching at Creon's feet, Medea begs him in the name of her children to allow her one day's delay. At this Creon is moved and grants to her one more day in Corinth. Medea's unexpected power of persuasion or even of fascination lies in her change of attitude: instead of preaching to Creon about the unpopularity of the sophoi she plays the role of a desperate mother, needing one day to prepare for exile. Medea is aware of the humiliating quality of this tactic, but she justifies it on the grounds of a gain and of her need to remain in Corinth: "Do you think that I would ever have flattered that man unless I had some gain to make or some device to execute? I wouldn't have even spoken or touched him with my hands". In the next scene Jason arrives to explain his rationale for his apparent betrayal.
Protriptyline, sold under the brand name Vivactil among others, is a tricyclic antidepressant (TCA), specifically a secondary amine. Uniquely among most of the TCAs, protriptyline tends to be energizing instead of sedating, and is sometimes used for narcolepsy to achieve a wakefulness-promoting effect. TCAs including protriptyline are also used to reduce the incidence of recurring headaches such as migraine, and for other types of chronic pain.
Sources: en.wikipedia.org
Caelus, the sky god, spreading the tent of the sky Aurora and Luna the personification of the subjected peoples the goddess Diana the earth goddess Ceres/Tellus—similarly represented on the Ara Pacis Apollo, Augustus's patron the personification of the tributary peoples the sun god Sol a Sphinx on each shoulder, representing the defeat of Cleopatra by Augustus The cuirass is not solely frontal; there is a backside to the armor as well. On the bottom right side of the back of the cuirass, there is a helmeted trophy with a wing above, a carnyx on the left hip, and greaves against a tree trunk. There was an iron peg that is thought to have connected the statue to a wall. This is likely due to the back being unfinished None of these interpretations are undisputed. The gods, however, probably all symbolize the continuity and logical consistency of the events—just as the sun and moon forever rise, so Roman successes are certain and divinely sanctioned. Furthermore, these successes are connected with the wearer of this breastplate, Augustus. The only active person is the Parthian king, implying that everything else is divinely desired and ordained.
==== TPN-based cholestasis ==== Total parenteral nutrition (TPN) is given to patients with intestinal failure or a variety of other gastrointestinal problems. Under normal settings, TPN causes a slight elevation of ALP levels. However, this does not indicate cholestasis alone. In the case of TPN-induced cholestasis, there is an excessive elevation of ALP, gamma-glutamyltransferase (GGT), and conjugated bilirubin. Without appropriate intervention, symptoms can quickly exacerbate, leading to liver cirrhosis and failure. Cholestasis arising from TPN has a diverse range of causes, including toxicity to TPN components, underlying disorders, or a lack of enteral nutrition. Without enteral food consumption, gallbladder function is greatly inhibited, leading to gallstone formation, subsequent blockage, and eventually cholestasis. Cholestasis resulting from TPN may also be a result of reduced bile flow from portal endotoxins. With TPN, there is a reduction in gastrointestinal motility, immunity, with an increase in permeability. These changes facilitate bacteria growth and increase the amount of circulating endotoxin. Moreover, given that patients using TPN often have underlying health problems, drugs being used with known liver toxicity may also cause cholestasis. Lipids in TPN may cause cholestasis and liver damage by overwhelming clearage mechanisms. Intravenous glucose can also cause cholestasis as a result of increased fatty acid synthesis and decreased breakdown, which facilitates the accumulation of fats.
== Paleontology == Moscow has internationally significant paleontological monuments in its area. One of these is the Gorodnya River with its tributaries, on the banks of which are located outcrops of the Quaternary and older Cretaceous periods. Fossils of the bivalve mollusk Inoceramus kleinii and tubular passages of burrowing animals—described in 2017 as a new ichnospecies, Skolithos gorodnensis—were discovered in Coniacian deposits near the stream bed of the Bolshaya Glinka River. The trace fossils Ichnogenera Diplocraterion, Planolites, Skolithos, and possibly Ophiomorpha were found in Albian deposits. Paleolithic flint tools were discovered in the Quaternary deposits of the Bolshaya Glinka stream bed. In 1878, paleontologist Hermann Trautschold discovered the left flipper of an ichthyosaur (an extinct large marine reptile) near the village of Mnevniki, which later became part of Moscow. In 2014, this ichthyosaur was named Undorosaurus trautscholdi, after its discoverer. Trautschold determined the age of the sediments from which the specimen was taken to be Kimmeridgian; however, according to more recent studies, these sediments were formed during the Tithonian age of the Jurassic period. Other organisms—Albian foraminifera and ammonites—are also known from Moscow deposits. Fossils of various organisms are displayed in Moscow museums, including the Orlov Museum of Paleontology and the Vernadsky State Geological Museum.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.